Correction: The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators
Mol Omics. 2021 Aug 9;17(4):641.
doi: 10.1039/d1mo90014e.
1 Anhui Clinical and Preclinical Key Laboratory of Respiratory Disease, Department of Respiratory Disease, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China. xzhu@gdmu.edu.cn bioxzhu@yahoo.com and Guangdong Key Laboratory for Research and Development of Natural Drugs, The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang 524023, China.
2 Department of Gynecology, Maternity and Child Healthcare Hospital of Anhui Medical University, Hefei 230001, China.
3 Guangdong Key Laboratory for Research and Development of Natural Drugs, The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang 524023, China.
4 Anhui Clinical and Preclinical Key Laboratory of Respiratory Disease, Department of Respiratory Disease, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China. xzhu@gdmu.edu.cn bioxzhu@yahoo.com and Guangdong Key Laboratory for Research and Development of Natural Drugs, The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang 524023, China and Guangdong Provincial Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, Department of Urology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital (Shenzhen Institute of Translational Medicine), Shenzhen 518035, China.
Correction for 'The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators' by Zhilin Zou et al., Mol. Omics, 2021, 17, 438-453, DOI: 10.1039/d0mo00113a.